Opinion
Video
Author(s):
Andrew Brunner, MD, presents the profile of a 72-year-old man with MDS and the panel offers their initial impressions on the case, focusing on the treatment decisions.
Asciminib Bests Standard-of-Care TKIs in Ph+ CML
Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
Vanderbilt Symposium Highlights Recent Data on Novel Agents Under Evaluation in Hematologic Malignancies
Revisit the OncLive On Air Episodes From February 2024
CAR T-Cell Therapies Move Ahead in Pediatric and Adult ALL
WU-CART-007 Receives FDA RMAT and EMA PRIME Designations for R/R T-ALL and T-LBL
Lorlatinib Yields Longest Reported PFS in Advanced NSCLC
Rivoceranib Plus Camrelizumab Maintains Frontline Survival Benefit in Unresectable HCC
Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma
Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth